Trial intelligence / Profile preview

Erythropoietin for Restenosis in AMI (EPOC-AMI)

NCT00423020Phase 4Unknown

Sponsor
Kyoto Prefectural University of Medicine
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of erythropoietin in acute myocardial infarction (AMI), sponsored by Kyoto Prefectural University of Medicine. Status: unknown.

02

Drugs

erythropoietin
03

Conditions

acute myocardial infarction (AMI)

Beyond the preview

Go deeper on NCT00423020.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00423020.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call